Literature DB >> 28097408

Primary Hyperparathyroidism with Normal Calcium and PTH.

Pedro Weslley Rosário1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28097408     DOI： 10.1007/s00268-017-3888-8

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  4 in total

1.  Use of Calcium and Parathyroid Hormone Nomogram to Distinguish Between Atypical Primary Hyperparathyroidism and Normal Patients.

Authors:  Olga A Lavryk; Allan E Siperstein
Journal:  World J Surg       Date:  2017-01       Impact factor: 3.352

2.  Screening for Hyperparathyroidism by Measurement of Calcium in Patients Undergoing Thyroid Surgery: A Prospective Study.

Authors:  P W Rosário; G F Mourão; M R Calsolari
Journal:  Horm Metab Res       Date:  2016-09-02       Impact factor: 2.936

3.  Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago.

Authors:  Ewa Lundgren; Emil G Hagström; Jonas Lundin; Kajsa Winnerbäck; Johanna Roos; Sverker Ljunghall; Jonas Rastad
Journal:  World J Surg       Date:  2002-06-06       Impact factor: 3.352

4.  Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop.

Authors:  Richard Eastell; Maria Luisa Brandi; Aline G Costa; Pierre D'Amour; Dolores M Shoback; Rajesh V Thakker
Journal:  J Clin Endocrinol Metab       Date:  2014-08-27       Impact factor: 5.958
  4 in total
  2 in total

Review 1.  Primary Hyperparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2018-11-01       Impact factor: 5.958

2.  Intraoperative parathyroid hormone (PTH) testing in patients with primary hyperparathyroidism and PTH levels in the normal range.

Authors:  Fabio Medas; Enrico Erdas; Giulia Loi; Francesco Podda; Lucia Barca; Giuseppe Pisano; Pietro Giorgio Calò
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.